esketamine
Articles tagged with “esketamine”

Side Effects & Dropout Rates: New Data on Ketamine for TRD
New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insight for patients considering ketamine therapy for TRD.
Why Patients Quit NMDA Therapy—And What Providers Should Do
New clinical review urges faster dose optimization and earlier switching between NMDA therapies for treatment-resistant depression. Here's what it means for patients.
When to Push for Stronger TRD Treatments, Per Experts
Psychiatric Times highlights underuse of highly effective TRD treatments. Here's what this means if you or a loved one is stuck in a cycle of failed antidepressants.
NMDA Side Effects: What Dropout Rates Mean for Patients
New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insights for patients considering ketamine or esketamine therapy.
Ketamine Side Effects: What New Clinical Data Reveals
New clinical analysis examines side effect profiles and discontinuation rates for ketamine and esketamine. Here's what treatment-resistant depression patients should know.
Ketamine Side Effects: What New Data Tells Patients
A new clinical review examines side effect profiles and discontinuation rates for NMDA antagonists like ketamine and esketamine. Here's what patients should know.
Ketamine Side Effects: What New Data Means for Patients
New clinical guidance on NMDA antagonist side effects and discontinuation rates gives patients and families sharper questions to ask before starting ketamine therapy.
How Doctors Choose Ketamine vs. Other TRD Treatments
New clinical guidance explains how psychiatrists choose between esketamine, ketamine, and brain stimulation for treatment-resistant depression patients.
Esketamine's Role in Treatment-Resistant Depression Care
New clinical guidance on esketamine for treatment-resistant depression highlights patient preferences, access barriers, and rapid-acting options for suicidal depression.
Generic Ketamine vs Spravato: Comparing Off-Label and FDA-Approved Options
A comprehensive comparison of generic (racemic) ketamine and Spravato (esketamine nasal spray) — covering FDA approval, effectiveness, cost, insurance coverage, and how to choose between them.
What a Spravato (Esketamine) Nasal Spray Session Is Really Like
What a Spravato nasal spray session feels like from start to finish — the check-in, administration, monitoring period, and what to expect during your visit.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.